ATSENA THERAPEUTICS, INC.
Profile
Company Names
ATSENA THERAPEUTICS, INC.
Addresses
8 DAVIS DRIVE, SUITE 300, DURHAM, NC 27709
701 W MAIN STREET, SUITE 200, DURHAM, NC 27701
280 S. MAGNUM STREET, SUITE 350, DURHAM, NC 27701
Phone Numbers
984-261-2001
302-290-5544
352-273-9342
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$146,049,324.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-03-27
$89,999,975.00
$150,000,000.00
$60,000,025.00
Equity
3
2023-08-28
$24,474,387.00
$32,000,000.00
$7,525,613.00
Equity
2
2020-12-15
$27,499,973.00
$55,000,000.00
$27,500,027.00
Equity
1
2020-04-24
$4,074,989.00
$8,149,978.00
$4,074,989.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
DIAL
DIRECTOR
JAMES
HEALY
DIRECTOR
GFP MANAGED EQUITIES I LP
| DXTERITY DIAGNOSTICS INC
| SORBENT THERAPEUTICS INC
| HYPERION THERAPEUTICS INC
| DFMSIM INC
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| KALOBIOS PHARMACEUTICALS INC
| GRAN PARADISO CAPITAL PARTNERS, LLC
| ASCENDIS PHARMA A/S
| CAPRA IBEX CLO INVESTOR, LLC
| BOLT BIOTHERAPEUTICS, INC.
| SOFINNOVA SYNERGY MASTER FUND, LP
| ARRIVENT BIOPHARMA, INC.
| ATSENA THERAPEUTICS, INC.
| BIOAGE LABS, INC.
NORBERT
RIEDEL
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
